Kuan Arthur has filed 8 insider transactions across 1 company since October 2024.
Most recent transaction: a option exercise of 64612 shares of CG Oncology, Inc. ($CGON) on March 12, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | CG Oncology, Inc. | $CGON | Kuan Arthur | Chief Executive Officer | M | Employee Stock Option (Right to Buy) | 64612 | $0.00 | 0.0000 | 80,666,179 | 100.00% | 0.08% |
| March 12, 2026 | CG Oncology, Inc. | $CGON | Kuan Arthur | Chief Executive Officer | F | Common Stock | 1847 | $60.15 | 198,916.0000 | 80,666,179 | 0.92% | 0.00% |
| March 12, 2026 | CG Oncology, Inc. | $CGON | Kuan Arthur | Chief Executive Officer | M | Common Stock | 64612 | $1.72 | 200,763.0000 | 80,666,179 | 47.46% | 0.08% |
| March 4, 2026 | CG Oncology, Inc. | $CGON | Kuan Arthur | Chief Executive Officer | M | Employee Stock Option (Right to Buy) | 102871 | $0.00 | 64,612.0000 | 80,666,179 | 61.42% | 0.13% |
| March 4, 2026 | CG Oncology, Inc. | $CGON | Kuan Arthur | Chief Executive Officer | M | Common Stock | 102871 | $1.72 | 139,022.0000 | 80,666,179 | 284.56% | 0.13% |
| March 4, 2026 | CG Oncology, Inc. | $CGON | Kuan Arthur | Chief Executive Officer | F | Common Stock | 2871 | $61.61 | 136,151.0000 | 80,666,179 | 2.07% | 0.00% |
| April 15, 2025 | CG Oncology, Inc. | $CGON | Kuan Arthur | Chief Executive Officer | A | Employee Stock Option (Right to Buy) | 527660 | $0.00 | 527,660.0000 | 76,216,855 | 9999.99% | 0.69% |
| Oct. 4, 2024 | CG Oncology, Inc. | $CGON | Kuan Arthur | Chief Executive Officer | A | Stock Option (Right to Buy) | 397800 | $0.00 | 397,800.0000 | 0 | 9999.99% | 0.00% |